Diabetes therapy
Researchers at Vanderbilt University Medical Center have identified a genetic variant in the glucagon-like peptide-1 receptor (GLP-1R) that influences the effectiveness of liraglutide, a medication used to treat obesity and pre-diabetes. The study, published in the Journal of Endocrinology, found that individuals with the variant allele (rs6923761) experienced greater weight
Adults
A recent study published in Frontiers in Public Health has shed light on the factors influencing type 2 diabetes mellitus (T2DM) among adults in Zhejiang Province, China. The study employed a stratified cluster sampling technique, involving 5,804 adults without known diabetes, and assessed various factors including food consumption, blood
Diabetes therapy
Research has shown that community pharmacists face challenges in providing effective patient education on continuous glucose monitors (CGMs), which are crucial for diabetes management. According to a recent study, limited time and resources may result in inadequate or absent counseling, potentially impacting the accuracy and accessibility of CGM use. Key
Diabetes therapy
A new study has shed light on the relationship between workplace culture of health and diabetes self-management behaviors among employees with type 2 diabetes in urban China. The research, conducted by investigators at Shanxi Medical University, recruited 462 employees with type 2 diabetes from three tertiary hospitals in Taiyuan City,
Dementia
Recent research conducted by investigators at McGill University suggests that incretin-based drugs, namely glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and dipeptidyl peptidase 4 (DPP-4) inhibitors, may have neuroprotective effects and be associated with a decreased risk of dementia among patients with type 2 diabetes. Using data from the Clinical
Dementia
Recent research conducted by investigators at McGill University suggests that incretin-based drugs, namely glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and dipeptidyl peptidase 4 (DPP-4) inhibitors, may have neuroprotective effects and be associated with a decreased risk of dementia among patients with type 2 diabetes. Using data from the Clinical
Diabetes therapy
A systematic review and meta-analysis conducted by researchers from Beihua University found that nurse-led interventions significantly improved self-management behaviours and self-efficacy in individuals with type 2 diabetes mellitus. The study, published in the International Journal of Nursing Practice, aimed to evaluate the effectiveness of nurse-led self-management interventions on self-management behaviours
Diabetes therapy
A new study published in the Journal of Diabetes and its Complications has compared the long-term clinical and economic outcomes of chiglitazar and sitagliptin in patients with type 2 diabetes mellitus (T2DM) in China. The research, conducted by a team of investigators from Shenzhen University, aimed to evaluate the cost-effectiveness
Adults
A recent study published in Frontiers in Public Health has shed light on the factors influencing type 2 diabetes mellitus (T2DM) among adults in Zhejiang Province, China. The study employed a stratified cluster sampling technique, involving 5,804 adults without known diabetes, and assessed various factors including food consumption, blood
Adults
A recent study published in Frontiers in Public Health has shed light on the factors influencing type 2 diabetes mellitus (T2DM) among adults in Zhejiang Province, China. The study employed a stratified cluster sampling technique, involving 5,804 adults without known diabetes, and assessed various factors including food consumption, blood
Diabetes therapy
A new study published in the Journal of Diabetes and its Complications has compared the long-term clinical and economic outcomes of chiglitazar and sitagliptin in patients with type 2 diabetes mellitus (T2DM) in China. The research, conducted by a team of investigators from Shenzhen University, aimed to evaluate the cost-effectiveness
Diabetes therapy
A new study published in the Journal of Diabetes and its Complications has compared the long-term clinical and economic outcomes of chiglitazar and sitagliptin in patients with type 2 diabetes mellitus (T2DM) in China. The research, conducted by a team of investigators from Shenzhen University, aimed to evaluate the cost-effectiveness
